Satoshi Miyamoto - Concepedia

Author

Satoshi Miyamoto

University of Tsukuba ORCID

Also Known As

M Miyaji, S Miyamoto, S. MIYAMOTO, S. Miyamoto, Sadaaki Miyamoto, Satoshi MIYAMOTO, Satoshi Miyamoto

129

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Tsukuba Okayama University Okayama University Hospital VA San Diego Healthcare System University of California San Diego

About

Satoshi Miyamoto is an author at University of Tsukuba specializing in medicine, engineering, and data science.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	986
2	Engineering	12	16	408
3	Biochemistry	7	7	319
4	Health Sciences	2	2	499
5	Natural Sciences	2	2	55

Satoshi Miyamoto

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function Laura L. Dugan, Young-Hyun You, Sameh S. Ali, Journal of Clinical Investigation	2013	442
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes Ryo Kodera, Kenichi Shikata, Hitomi Kataoka, Diabetologia InflammationMetabolic SyndromeType 1MedicineDiabetes	2011	378
Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator Satoshi Miyamoto, Cheng‐Chih Hsu, Grégory Hamm, EBioMedicine Metabolic DisorderIdentifies SphingomyelinRenal PathologyRenal InflammationInsulin Signaling	2016	121
Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes Ryo Kodera, Kenichi Shikata, Tetsuharu Takatsuka, Biochemical and Biophysical Research Communications InflammationType 1UrologyRenal FunctionAutoimmune Disease	2013	99
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Fuzzy clustering by quadratic regularization Satoshi Miyamoto, Kazutaka Umayahara Fuzzy LogicEngineeringFuzzy ComputingData ScienceData Mining	2002	86
Gut Microbial Changes in Diabetic db/db Mice and Recovery of Microbial Diversity upon Pirfenidone Treatment Harinder Singh, Satoshi Miyamoto, Manjula Darshi, Microorganisms	2020	81
Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease Hui Li, Joseph Satriano, Joanna Thomas, American Journal of Physiology-Renal Physiology Cell DeathRedox BiologyCellular PhysiologyOxidative StressRenal Function	2015	74
Cholecystokinin Plays a Novel Protective Role in Diabetic Kidney Through Anti-inflammatory Actions on Macrophage Satoshi Miyamoto, Kenichi Shikata, Kyoko Miyasaka, Diabetes Diabetic Cck-1rDiabetic KidneyImmunologyRenal InflammationCck-1 Receptor	2012	70
Information retrieval based on fuzzy associations Satoshi Miyamoto Fuzzy Sets and Systems Fuzzy AssociationsFuzzy LogicEngineeringInformation RetrievalData Science	1990	67

Page 1